Heart failure etiology and response tomilrinone in decompensated heart failure
Authors:
- G.Michael FelkerGFG.Michael Felker
- Raymond L BenzaRBRaymond L Benza
- A.Bleakley ChandlerACA.Bleakley Chandler
- Jeffrey D LeimbergerJLJeffrey D Leimberger
- Michael S CuffeMCMichael S Cuffe
- Robert M CaliffRCRobert M Califf
- Mihai GheorghiadeMGMihai Gheorghiade
- Christopher M O’connorCOChristopher M O’connor
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Underlying Causes and Long-Term Survival in Patients with Initially Unexplained CardiomyopathyNew England Journal of Medicine, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart FailureJACC, 1996
- Inotropic stimulation by dobutamine increases left ventricular regional function at the expense of metabolism in hibernating myocardiumAmerican Heart Journal, 1996
- Xamoterol in severe heart failureThe Lancet, 1990
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathyThe American Journal of Cardiology, 1987
- The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathyAmerican Heart Journal, 1983
- Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.Circulation, 1982